Generic APIs at Crossroads - 3: Gx Society Sets Up Committee for Discussions with Healthcare Providers and API Manufacturers

Hiroto Yoshiwaka, Councilor, Japanese Society of Generic and Biosimilar Medicines The Japanese Society of Generic and Biosimilar Medicines established an “API committee” in April as a forum for healthcare providers, API manufacturers, and API trading companies to discuss the various...read more